CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1, Open-Label, Multicenter, Dose Escalation, Dose Expansion Study of PRT543 in Patients With Advanced Solid Tumors and Hematologic Malignancies
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT03886831
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:39:15.123670+00:00
- Published At
- 2023-03-28T00:00:00+00:00
- Record Updated At
- 2023-03-28
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Relapsed/Refractory Advanced Solid Tumors", "Relapsed/Refractory Diffuse Large B-cell Lymphoma", "Relapsed/Refractory Myelodysplasia", "Relapsed/Refractory Myelofibrosis", "Adenoid Cystic Carcinoma", "Relapsed/Refractory Mantle Cell Lymphoma", "Relapsed/Refractory Acute Myeloid Leukemia", "Refractory Chronic Myelomonocytic Leukemia"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-03-28"- protocolSection.identificationModule.nctId
"NCT03886831"- protocolSection.identificationModule.officialTitle
"A Phase 1, Open-Label, Multicenter, Dose Escalation, Dose Expansion Study of PRT543 in Patients With Advanced Solid Tumors and Hematologic Malignancies"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.